Selective p38α mitogen-activated protein kinase inhibitor attenuates lung inflammation and fibrosis in IL-13 transgenic mouse model of asthma

Overview of attention for article published in Journal of Asthma and Allergy, November 2008

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 15 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 17 publications that cite this research output.

17

The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.

SB203580—A Potent p38 MAPK Inhibitor Reduces the Profibrotic Bronchial Fibroblasts Transition Associated with Asthma

Article in International Journal of Molecular Sciences (November 2021)

Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secretory Fibrotic Disorders

Article in Frontiers in Immunology (July 2021)

Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies

Article in Drug Design Development and Therapy (March 2021)